An audit of holotranscobalamin ("Active" B12) and methylmalonic acid assays for the assessment of vitamin B12 status: Application in a mixed patient population

Clinical Biochemistry

Volumn 47, Issue 1-2, 2014, Pages 82-86

  Sobczyńska Malefora, Agata ^a   Gorska, Renata ^a   Pelisser, Michel ^a   Ruwona, Patricia ^a   Witchlow, Bernie ^a   Harrington, Dominic J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

"Active" vitamin B12; Holotranscobalamin; Methylmalonic acid; Reference ranges; Renal function; Vitamin B12

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOLOTRANSCOBALAMIN; METHYLMALONIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CREATININE BLOOD LEVEL; ELECTROSPRAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFANT; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NUTRITIONAL STATUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL;

" ACTIVE" VITAMIN B(12); HOLOTRANSCOBALAMIN; METHYLMALONIC ACID; REFERENCE RANGES; RENAL FUNCTION; VITAMIN B(12);

BIOLOGICAL MARKERS; HUMANS; METHYLMALONIC ACID; TRANSCOBALAMINS; VITAMIN B 12;

EID: 84890558502     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.08.006     Document Type: Article

References (33)

1. 12. Report of a joint FAO/WHO expert consultation Bangkok, Thailand 2002, 65-72. Publishing and Multimedia Service, Rome.
2. 12 - cobalamin. Vitamins in the prevention of human diseases 2011, 187-271. De Gruyter, Berlin. W. Herrmann, R. Obeid (Eds.).
3. 12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyper-homocysteinemia in vegetarians. Am J Clin Nutr 2003, 78:131-136.
4. Lindenbaum J., Healton E.B., Savage D.G., Brust J.C.M., Garrett T.J., Podell E.R., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988, 318:1720-1728.
5. Lindenbaum J., Savage D.G., Stabler S.P., Allen R.H. Diagnosis of cobalamin deficiency II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990, 34:99-107.
6. 12 status. Clin Chem 2009, 55:2198-2206.
7. Rasmussen K., Vyberg B., Pedersen K.O., Brochner-Mortensen J. Methylmalonic acid in renal-insufficiency - evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990, 36:1523-1524.
8. Holleland G., Schneede J., Ueland P.M., Lund P.K., Refsum H., Sandberg S. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem 1999, 45:189-198.
9. 12 status in different clinical settings. Curr Drug Metab 2005, 6:47-53.
10. 12 status in the elderly. Clin Chem 2011, 57:856-863.
11. Morkbak A.L., Hvas A.M., Milman N., Nexo E. Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 2007, 92:1711-1712.
12. 12 deficiency: a multicentre study. Ann Clin Biochem 2012, 49:184-189.
13. 12 deficiency. Clin Chem 2003, 49:2076-2078.
14. Nexo E., Hvas A.M., Bleie O., Refsum H., Fedosov S.N., Vollset S.E., et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem 2002, 48:1768-1771.
15. 12: a rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer. Clin Chem 2008, 54:567-573.
16. 12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003, 41:1478-1488.
17. Obeid R., Jouma M., Herrmann W. Cobalamin status (holo-transcobalamin, methylmalonic acid) and folate as determinants of homocysteine concentration. Clin Chem 2002, 48:2064-2065.
18. Refsum H., Yajnik C.S., Gadkari M., Schneede J., Vollset S.E., Orning L., et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001, 74:233-241.
19. Blom H.J., van Rooij A., Hogeveen M. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2007, 45:645-650.
20. Erdogan E., Nelson G.J., Rockwood A.L., Frank E.L. Evaluation of reference intervals for methylmalonic acid in plasma/serum and urine. Clin Chim Acta 2010, 411:1827-1829.
21. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
22. Ulleland M., Eilertsen I., Quadros E.V., Rothenberg S.P., Fedosov S.N., Sundrehagen E., et al. Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 2002, 48:526-532.
23. 12 assay: cut-off point evaluation in the clinical laboratory. Clin Chem Lab Med 2010, 48:249-253.
24. Obeid R., Herrmann W. Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid. Clin Chem Lab Med 2007, 45:1746-1750.
25. Refsum H., Johnston C., Guttormsen A.B., Nexo E. Holotranscobalamin and total transcobalamin in human plasma: determination, determinants, and reference values in healthy adults. Clin Chem 2006, 52:129-137.
26. 12 deficiency syndromes. J Neurol 2011, 258:393-401.
27. 6: a randomised trial. Eur J Clin Nutr 2003, 57:1426-1436.
28. 12 (cobalamin) status in vegetarians. Am J Clin Nutr 1994, 59:1213S-1222S.
29. 12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011, 94:359S-365S.
30. Carmel R., Vasireddy H., Aurangzeb I., George K. High serum cobalamin levels in the clinical setting - clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001, 23:365-371.
31. 12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 2011, 94:348S-358S.
32. Hoffmann-Lucke E., Arendt J.F., Nissen P.H., Mikkelsen G., Aasly J.O., Nexo E. Three family members with elevated plasma cobalamin, transcobalamin and soluble transcobalamin receptor (sCD320). Clin Chem Lab Med 2013, 51:677-682.
33. Arendt J.F., Nexo E. Unexpected high plasma cobalamin/proposal for a diagnostic strategy. Clin Chem Lab Med 2013, 51:489-496.